Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug;16(3):e359-63.
doi: 10.18295/squmj.2016.16.03.017. Epub 2016 Aug 19.

A Combination of Drug-Eluting Stents and Bioresorbable Vascular Scaffolds in the Treatment of Multivessel Coronary Artery Disease

Affiliations

A Combination of Drug-Eluting Stents and Bioresorbable Vascular Scaffolds in the Treatment of Multivessel Coronary Artery Disease

Ahmed Al-Mamary et al. Sultan Qaboos Univ Med J. 2016 Aug.

Abstract

Optimal management of multivessel coronary artery disease can be complex. We report a 67-year-old male patient who was admitted to the Padua University Hospital, Padua, Italy, in 2014 with a non-ST-elevation myocardial infarction. Coronary angiography showed diffuse multiple sub-occlusive lesions of the proximal and distal left coronary vessels involving a long segment of the vessel. On intravascular ultrasonography (IVUS), the left main artery was moderately diseased with critically stenotic and calcified branch ostia. A successful percutaneous coronary intervention using the T-stenting and small protrusion technique with two drug-eluting stents (DES) was performed on the left main artery and its main branches. Two bioresorbable vascular scaffolds were also deployed in overlap at the mid to distal segments of the left anterior descending artery and overlapping a previous DES at the proximal segment. The full expansion and apposition of the struts and scaffolds to the vessel wall without residual stenosis was confirmed by IVUS.

Keywords: Case Report; Coronary Stenosis; Drug-Eluting Stents; Italy; Myocardial Infarction; Percutaneous Coronary Intervention; Ultrasonography.

PubMed Disclaimer

Figures

Figure 1A–C:
Figure 1A–C:
Coronary angiography of a 67-year-old male patient from the (A) cranial right anterior oblique (RAO), (B) caudal RAO and (C) caudal left anterior oblique views showing multiple diffuse critical lesions of the proximal and distal segments of the left coronary arteries involving the left main trunk with a hazy proximal left circumflex artery (LCx) lesion. Despite evaluation from several planes, the stenosis of the proximal LCx artery remained unclear.
Figure 2A–C:
Figure 2A–C:
Intravascular ultrasonography (IVUS) of a 67-year-old male patient showing (A) moderate left main trunk disease, (B) multiple significant stenoses of the left anterior descending artery and (C) stenosis of the proximal left circumflex artery with eccentric superficial and deep dense calcific plaque (arrow). MLA = minimal lumen area.
Figure 3A–C:
Figure 3A–C:
Post-interventional cross-sectional intravascular ultrasonography of a 67-year-old male patient following the implantation of two bioresorbable vascular scaffolds and two drug-eluting stents. The stents were well-apposed and expanded with no signs of dissection at the (A) left main trunk, (B) proximal portion of the left anterior descending artery and (C) proximal portion of the left circumflex artery.
Figure 4A–C:
Figure 4A–C:
A: Post-interventional coronary angiography of a 67-year-old male patient following the implantation of two bioresorbable vascular scaffolds at the mid-distal portion of the left anterior descending artery and in overlap with a drug-eluting stent at the proximal portion. B and C: Cross-sectional intravascular ultrasonography images corresponding to sections of the coronary angiogram (yellow lines) showing the uniform and full expansion of the struts and scaffolds apposed to the intimo-medial membrane. All three concentric stents and scaffold layers were noted at overlap sites as discrete echo-bright structures. DES = drug-eluting stent; BVS = bioresorbable vascular scaffold.

Similar articles

References

    1. Parikh PB, Kirtane AJ, Moses JW. Management of multivessel coronary artery disease. Panminerva Med. 2013;55:311–26. - PubMed
    1. Kolh P, Windecker S, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) - Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur J Cardiothorac Surg. 2014;46:517–92. doi: 10.1093/ejcts/ezu366. - DOI - PubMed
    1. Deb S, Wijeysundera HC, Ko DT, Tsubota H, Hill S, Fremes SE. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: A systematic review. JAMA. 2013;310:2085–95. doi: 10.1001/jama.2013.281718. - DOI - PubMed
    1. Dangas GD, Farkouh ME, Sleeper LA, Yang M, Schoos MM, Macaya C, et al. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: Results from the FREEDOM trial. J Am Coll Cardiol. 2014;64:1189–97. doi: 10.1016/j.jacc.2014.06.1182. - DOI - PubMed
    1. Nicolini F, Agostinelli A, Vezzani A, Benassi F, Gherli T. CABG versus PCI in the treatment of diabetic patients affected by coronary artery disease: Which is the best option? Int Heart J. 2014;55:469–73. doi: 10.1536/ihj.14-061. - DOI - PubMed

LinkOut - more resources